PLG Nanoparticle-Based Antigen Delivery for The Tolerogenic Treatment of Autoreactive T & B Cell Responses in a Mouse Model of Neuromyelitis Optica (NMO)
Time: 1:00 pm
day: Day Two
Details:
- Review the mechanisms of PLG nanoparticle-induced tolerance and its
- translational potential in a Phase 1/2a clinical trial in celiac disease
- Describe the requirements for induction of a new mouse model of NMO
- Decipher the efficacy of tolerance using PLG nanoparticle
